{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:36Z","timestamp":1786985016113,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbi.2025.106135","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:32:45Z","timestamp":1760571165000},"page":"106135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Systematic screening identifies medication and disease factors associated with schizophrenia risk"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4389-8896","authenticated-orcid":false,"given":"Ariel","family":"Israel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Stokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Vinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Merzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.106135_b0005","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0010","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM), edition (5th. 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.bbi.2025.106135_b0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/schbul\/sbs043","article-title":"Toxoplasma gondii and other Risk Factors for Schizophrenia: an Update","volume":"38","author":"Torrey","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.106135_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067873","article-title":"Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study","volume":"375","author":"Israel","year":"2021","journal-title":"The BMJ"},{"key":"10.1016\/j.bbi.2025.106135_b0025","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41380-021-01025-0","article-title":"Vitamin D and schizophrenia: 20 years on","volume":"26","author":"Cui","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0030","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1038\/s41598-018-29141-y","article-title":"Vitamin D, Folate and the Intracranial volume in Schizophrenia and Bipolar Disorder and healthy Controls","volume":"8","author":"Gurholt","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106135_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110402","article-title":"Thyroid hormones in persons with schizophrenia: a systematic review and meta-analysis","volume":"111","author":"Misiak","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"de Leon","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.106135_b0045","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbae228","article-title":"The Prevalence of attention Deficit Hyperactivity Disorder in Psychotic Disorders: Systematic Review and Meta-analysis","author":"Cheng","year":"2025","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.106135_b0050","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/schbul\/sbt200","article-title":"Hospital Contacts with Infection and risk of Schizophrenia: a Population-based Cohort Study with Linkage of danish National Registers","volume":"40","author":"Nielsen","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.106135_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12671","article-title":"Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2025.106135_b0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/schbul\/sbm021","article-title":"Anti-Toxoplasma gondii Antibodies in patients with Schizophrenia-Preliminary Findings in a Turkish Sample","volume":"33","author":"Cetinkaya","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.106135_b0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/acps.12423","article-title":"Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta\u2010analysis","volume":"132","author":"Sutterland","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2025.106135_b0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00406-013-0413-4","article-title":"Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate","volume":"264","author":"Fond","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2025.106135_b0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JCP.0000000000001541","article-title":"Mania with Psychotic Symptoms after Malaria Prophylaxis with Atovaquone-Proguanil","volume":"42","author":"Rom\u00e3o Franco","year":"2022","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2025.106135_b0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/AAC.36.5.1091","article-title":"Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant","volume":"36","author":"Pfefferkorn","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2025.106135_b0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0190-9622(86)70076-5","article-title":"Cutaneous toxoplasmosis","volume":"14","author":"Leyva","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bbi.2025.106135_b0090","first-page":"61","article-title":"Topical Antimicrobial Treatments can Elicit Shifts to Resident Skin Bacterial Communities and Reduce Colonization by Staphylococcus aureus competitors","author":"SanMiguel","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2025.106135_b0095","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/AAC.44.10.2771-2776.2000","article-title":"Anti- Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of activity by Molecular Topology and Virtual Computational Techniques","volume":"44","author":"Gozalbes","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2025.106135_b0100","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1128\/AAC.43.7.1783","article-title":"Anti- Toxoplasma gondii Activities and Structure-activity Relationships of Novel Fluoroquinolones Related to Trovafloxacin","volume":"43","author":"Khan","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2025.106135_b0105","first-page":"367","article-title":"The effect of minocycline, doxycycline and oxytetracycline on experimental mouse toxoplasmosis","volume":"69","author":"Perea","year":"1976","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"10.1016\/j.bbi.2025.106135_b0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3347\/kjp.2013.51.4.393","article-title":"Clinical Features and Treatment of Ocular Toxoplasmosis","volume":"51","author":"Park","year":"2013","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.bbi.2025.106135_b0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12888-020-02881-w","article-title":"Association of ocular diseases with schizophrenia, bipolar disorder, and major depressive disorder: a retrospective case-control, population-based study","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0120","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1462-5822.2006.00735.x","article-title":"Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination","volume":"8","author":"Lambert","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bbi.2025.106135_b0125","article-title":"The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations","volume":"24","author":"Colijn","year":"2022","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.bbi.2025.106135_b0130","article-title":"Alcohol drinking in male patients with chronic schizophrenia: prevalence and its relationship to clinical symptoms. Front","volume":"14","author":"Lv","year":"2023","journal-title":"Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.genhosppsych.2019.10.007","article-title":"Rates of hepatitis B and C in patients with schizophrenia: a meta-analysis","volume":"61","author":"Lluch","year":"2019","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.bbi.2025.106135_b0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of Hepatitis a in Israel following Universal Immunization of Toddlers","volume":"294","author":"Dagan","year":"2005","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbi.2025.106135_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2025.106135_b0150","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2025.106135_b0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2025.106135_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","article-title":"Efficacy of Anti-inflammatory Agents to Improve Symptoms in patients with Schizophrenia: an Update","volume":"40","author":"Sommer","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2025.106135_b0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2025.106135_b0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","article-title":"Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia","volume":"158","author":"Candelario-Jalil","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2025.106135_b0175","first-page":"5","article-title":"Opioid System Modulates the Immune Function: a Review","volume":"1","author":"Liang","year":"2016","journal-title":"Transl Perioper Pain Med"},{"key":"10.1016\/j.bbi.2025.106135_b0180","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.3390\/cimb44110386","article-title":"The Crosstalk between the Blood\u2013Brain Barrier Dysfunction and Neuroinflammation after General Anaesthesia","volume":"44","author":"Yang","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbi.2025.106135_b0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S1461145711001374","article-title":"Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree","volume":"15","author":"Teltsh","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.106135_b0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/cimb44010025","article-title":"The Role of OXT, OXTR, AVP, and AVPR1a Gene Expression in the Course of Schizophrenia","volume":"44","author":"Broniarczyk-Czarniak","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbi.2025.106135_b0195","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41598-019-57134-y","article-title":"Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis","volume":"10","author":"Vi\u00f1uela-Berni","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.106135_b0200","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/nu17071167","article-title":"Vitamin D, B9, and B12 Deficiencies as Key Drivers of Clinical Severity and Metabolic Comorbidities in Major Psychiatric Disorders","volume":"17","author":"Faugere","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2025.106135_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/biom15081094","article-title":"Vitamin D as a Modifiable Risk factor in Schizophrenia a Systematic Review","volume":"15","author":"Mosio\u0142ek","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbi.2025.106135_b0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mnfr.201000174","article-title":"A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency","volume":"55","author":"Schwalfenberg","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.bbi.2025.106135_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051248","article-title":"Vitamin D\u2019s effect on Immune Function","volume":"12","author":"Martens","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2025.106135_b0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2011.04.015","article-title":"Vitamin D metabolism and innate immunity","volume":"347","author":"Lagishetty","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbi.2025.106135_b0225","doi-asserted-by":"crossref","DOI":"10.15212\/ZOONOSES-2022-0019","article-title":"Lower Vitamin D Levels are Associated with Higher Seroprevalence of Toxoplasma gondii\u2014a US National Survey Study","volume":"2","author":"Huang","year":"2022","journal-title":"Zoonoses"},{"key":"10.1016\/j.bbi.2025.106135_b0230","article-title":"Toxoplasmosis in immunocompetent Saudi women: Correlation with vitamin D. Women\u2019s","volume":"17","author":"Rasheed","year":"2021","journal-title":"Health"},{"key":"10.1016\/j.bbi.2025.106135_b0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2012.05.023","article-title":"Childhood infection and adult schizophrenia: a meta-analysis of population-based studies","volume":"139","author":"Khandaker","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.106135_b0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2016.12.010","article-title":"The microbiome, immunity, and schizophrenia and bipolar disorder","volume":"62","author":"Dickerson","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2025.106135_b0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2014.06.027","article-title":"Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling","volume":"176","author":"Severance","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2025.106135_b0250","doi-asserted-by":"crossref","unstructured":"Szeligowski T, Yun AL, Lennox BR, Burnet PWJ. The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications. Front Psychiatry 2020; 11. doi:10.3389\/fpsyt.2020.00156.","DOI":"10.3389\/fpsyt.2020.00156"},{"key":"10.1016\/j.bbi.2025.106135_b0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41537-024-00497-7","article-title":"Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization","volume":"10","author":"Zhou","year":"2024","journal-title":"Schizophrenia"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:41:36Z","timestamp":1773279696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125003770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"alternative-id":["S0889159125003770"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106135","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic screening identifies medication and disease factors associated with schizophrenia risk","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106135"}}